Anatoly Yakovenko, co-founder of Solana Labs, posted a brief message urging data center operators to shift their focus toward cryptocurrency. He did not provide specifics on the type of crypto workloads or business changes involved, nor did he clarify if this is an immediate opportunity or a future trend. The post lacked further explanation, leaving the exact nature and timing of the proposed shift unclear. This call highlights potential growth areas for data centers in the crypto industry but remains vague on implementation.
Solana Labs co-founder Anatoly Yakovenko's call for data centers to pivot to crypto comes with a snapshot of the crypto market on Pluang. As of Nov 05, 2026 00:31 WIB, 45 out of 50 major cryptocurrencies rose in price. Notable movers include XNO at Rp6.028 with a 4.44% increase and 100% buy order activity, THETA at Rp2.851 up 4.43%, and UNI at Rp138.430 rising 4.33%.
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
